683 Capital Management, LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 2:35 pm Sale |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
683 Capital Management, LLC | 90,000 0.200% |
-1,842,829 (-95.34%) |
Filing |
| 2022-02-11 6:39 pm Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
683 Capital Management, LLC | 1,932,829 5.300% |
111,680 (+6.13%) |
Filing |
| 2021-01-11 5:00 pm Purchase |
2020-12-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
683 Capital Management, LLC | 1,821,149 5.100% |
1,821,149 (New Position) |
Filing |